U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801963) titled 'Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH' on Aug. 17.
Brief Summary: To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level on sleeping parameters by polygraphy in patients with pulmonary arterial hypertension PAH, who live permanently >2600m.
Study Start Date: Sept. 25
Study Type: INTERVENTIONAL
Condition:
Pulmonary Arterial Hypertension (PAH)
Pulmonary Vascular Disease
Polygraphy
Sleep
Sleep Disordered Breathing (SDB)
High Altitude Effects
High Altitude
Intervention:
BEHAVIORAL: Descent to sea level
Descent f...